These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17941851)

  • 1. Radiotherapy reduces sialorrhea in amyotrophic lateral sclerosis.
    Neppelberg E; Haugen DF; Thorsen L; Tysnes OB
    Eur J Neurol; 2007 Dec; 14(12):1373-7. PubMed ID: 17941851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing excessive saliva with salivary gland irradiation in patients with amyotrophic lateral sclerosis.
    Slade A; Stanic S
    J Neurol Sci; 2015 May; 352(1-2):34-6. PubMed ID: 25881952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary glands radiotherapy to reduce sialorrhea in amyotrophic lateral sclerosis: dose and energy.
    Bourry N; Guy N; Achard JL; Verrelle P; Clavelou P; Lapeyre M
    Cancer Radiother; 2013 Jun; 17(3):191-5. PubMed ID: 23517881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of radiotherapy types in the treatment of sialorrhea in amyotrophic lateral sclerosis.
    Guy N; Bourry N; Dallel R; Dualé C; Verrelle P; Lapeyre M; Clavelou P
    J Palliat Med; 2011 Apr; 14(4):391-5. PubMed ID: 21413884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis.
    Costa J; Rocha ML; Ferreira J; Evangelista T; Coelho M; de Carvalho M
    J Neurol; 2008 Apr; 255(4):545-50. PubMed ID: 18283399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation therapy for hypersalivation: a prospective study in 50 amyotrophic lateral sclerosis patients.
    Assouline A; Levy A; Abdelnour-Mallet M; Gonzalez-Bermejo J; Lenglet T; Le Forestier N; Salachas F; Bruneteau G; Meininger V; Delanian S; Pradat PF
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):589-95. PubMed ID: 24411632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unilateral parotid electron beam radiotherapy as palliative treatment for sialorrhea in amyotrophic lateral sclerosis.
    Kasarskis EJ; Hodskins J; St Clair WH
    J Neurol Sci; 2011 Sep; 308(1-2):155-7. PubMed ID: 21726879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin-A injections vs radiotherapy for drooling in ALS.
    Weikamp JG; Schinagl DA; Verstappen CC; Schelhaas HJ; de Swart BJ; Kalf JG
    Acta Neurol Scand; 2016 Sep; 134(3):224-31. PubMed ID: 26803950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin improves sialorrhea and quality of living in bulbar amyotrophic lateral sclerosis.
    Verma A; Steele J
    Muscle Nerve; 2006 Aug; 34(2):235-7. PubMed ID: 16583370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of radiotherapy for control of sialorrhea in patients with amyotrophic lateral sclerosis.
    Harriman M; Morrison M; Hay J; Revonta M; Eisen A; Lentle B
    J Otolaryngol; 2001 Aug; 30(4):242-5. PubMed ID: 11771037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Volume matters: the influence of different botulinum toxin-A dilutions for sialorrhea in amyotrophic lateral sclerosis.
    Anagnostou E; Rentzos M; Alexakis T; Zouvelou V; Zambelis T; Evdokimidis I
    Muscle Nerve; 2013 Feb; 47(2):276-8. PubMed ID: 23281147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of sialorrhea in amyotrophic lateral sclerosis.
    Tysnes OB
    Acta Neurol Scand Suppl; 2008; 188():77-81. PubMed ID: 18439227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute deterioration of bulbar function after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis.
    Meijer JW; van Kuijk AA; Geurts AC; Schelhaas HJ; Zwarts MJ
    Am J Phys Med Rehabil; 2008 Apr; 87(4):321-4. PubMed ID: 18303472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External radiation of the parotid glands significantly reduces drooling in patients with motor neurone disease with bulbar paresis.
    Andersen PM; Grönberg H; Franzen L; Funegård U
    J Neurol Sci; 2001 Oct; 191(1-2):111-4. PubMed ID: 11677000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of options for treating sialorrhea in amyotrophic lateral sclerosis.
    Banfi P; Ticozzi N; Lax A; Guidugli GA; Nicolini A; Silani V
    Respir Care; 2015 Mar; 60(3):446-54. PubMed ID: 25228780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of severe drooling with botulinum toxin in amyotrophic lateral sclerosis and Parkinson's disease: efficacy and possible mechanisms.
    Møller E; Karlsborg M; Bardow A; Lykkeaa J; Nissen FH; Bakke M
    Acta Odontol Scand; 2011 May; 69(3):151-7. PubMed ID: 21198339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sialorrhea in amyotrophic lateral sclerosis: a hypothesis of a new treatment--botulinum toxin A injections of the parotid glands.
    Bushara KO
    Med Hypotheses; 1997 Apr; 48(4):337-9. PubMed ID: 9160288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injections of botulinum toxin A into the salivary glands improve sialorrhoea in amyotrophic lateral sclerosis.
    Giess R; Naumann M; Werner E; Riemann R; Beck M; Puls I; Reiners C; Toyka KV
    J Neurol Neurosurg Psychiatry; 2000 Jul; 69(1):121-3. PubMed ID: 10864618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum Toxin A and B in sialorrhea: Long-term data and literature overview.
    Petracca M; Guidubaldi A; Ricciardi L; Ialongo T; Del Grande A; Mulas D; Di Stasio E; Bentivoglio AR
    Toxicon; 2015 Dec; 107(Pt A):129-40. PubMed ID: 26327120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent jaw dislocation after botulinum toxin treatment for sialorrhoea in amyotrophic lateral sclerosis.
    Tan EK; Lo YL; Seah A; Auchus AP
    J Neurol Sci; 2001 Sep; 190(1-2):95-7. PubMed ID: 11574113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.